$49.1M
The grant from the US Advanced Research Projects Agency for Health will support the POSEIDON programme for early oncology intervention.
"The field of cancer screening needs a revolution, and POSEIDON stands ready to deliver. The program allows for a better future by creating broadly accessible, at-home tests that will accurately detect 30+ cancers as early as Stage I, when tumours are still small and the chances of survival are high,"